R

RiverVest portfolio

RiverVest has 3 portfolio companies on record at Recent Funding. It led 1 of the 5 rounds it joined. Its most recent investment on record is Biolinq's $100M Series B+ round in April 2025, alongside Taisho Pharmaceutical Holdings, M Ventures, LifeSci Venture Partners and 5 others. By category, its portfolio leans toward Health and bio (3) and Data and analytics (1). It has co-invested with Taisho Pharmaceutical Holdings, M Ventures and Hikma Ventures, most often Taisho Pharmaceutical Holdings (2 rounds).

What RiverVest invests in

• Health and bio · 3 · 100%
• Data and analytics · 1 · 33%

RiverVest recent investments

Company	Round	Date	Alongside
BBiolinq	Series B+ · $100M	Apr 22, 2025	Taisho Pharmaceutical Holdings, M Ventures, LifeSci Venture Partners +5
EEngrail Therapeutics	Series B+ · $157M	Mar 19, 2024	Ysios Capital, Red Tree Venture Capital, Pivotal Life Sciences +6
AAvalyn Pharma	Series B+ · $100M	Sep 27, 2023	Wellington Management, Vida Ventures, T. Rowe Price +6
BBiolinq	Series B+ · $100M · lead	Nov 2, 2021	T&W Medical, The Broe Group, Taisho Pharmaceutical Holdings +6
AAvalyn Pharma	Series B+ · $35.5M	Apr 27, 2020	TPG Biotech, Pivotal bioVenture Partners, Novo Holdings +2

How RiverVest invests

Share is of the 5 rounds on Recent Funding that name RiverVest. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

RiverVest portfolio companies

• BBiolinq$100MSeries B+ · Apr 2025
• EEngrail Therapeutics$157MSeries B+ · Mar 2024
• AAvalyn Pharma$100MSeries B+ · Sep 2023

Company	Round with RiverVest	Total raised	Latest raise
BBiolinq Health and bio	Apr 22, 2025 Series B+ · $100M	$214.75M	Apr 22, 2025 Series B+
EEngrail Therapeutics Health and bio	Mar 19, 2024 Series B+ · $157M	$221M	Mar 19, 2024 Series B+
AAvalyn Pharma Health and bio	Sep 27, 2023 Series B+ · $100M	$135.5M	Sep 27, 2023 Series B+

Most frequent co-investors

• TTaisho Pharmaceutical Holdings2 shared rounds · last Apr 22, 2025
• MM Ventures2 shared rounds · last Apr 22, 2025
• HHikma Ventures2 shared rounds · last Apr 22, 2025
• FF-Prime Capital2 shared rounds · last Mar 19, 2024
• NNorwest Venture Partners2 shared rounds · last Mar 19, 2024
• TTPG Biotech2 shared rounds · last Sep 27, 2023
• PPivotal bioVenture Partners2 shared rounds · last Sep 27, 2023
• AAlpha Wave Ventures1 shared round · last Apr 22, 2025
• LLifeSci Venture Partners1 shared round · last Apr 22, 2025
• FFeatures Capital1 shared round · last Apr 22, 2025
• AAXA Alternative Investments1 shared round · last Apr 22, 2025
• AAphelion Capital1 shared round · last Apr 22, 2025

Similar investors

• PPositive Sum3 companies · 4 deals in 12 mo
• BBlue Cloud Ventures3 companies · 3 deals in 12 mo
• IInnovestor3 companies · 3 deals in 12 mo
• FFrazier Life Sciences3 companies · 2 deals in 12 mo
• KKadmos Capital3 companies · 2 deals in 12 mo
• KKorea Credit Guarantee Fund3 companies · 2 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists RiverVest, which is a subset of its real portfolio. API: /api/v1/investors/rivervest (get a free API key). More: the most active VC firms and new venture capital funds.